Prescriber's Corner

Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer

Nancy M. Nix, PharmD, BCPS, BCOP, and Kaitlyn S. Brown, PharmD(c)

St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, Hilton Head, South Carolina; University of Georgia College of Pharmacy, Athens, Georgia

Authors' disclosures of potential conflicts of interest are found at the end of this article.

Nancy M. Nix, PharmD, BCPS, BCOP, St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, PO Box 21824, Hilton Head, SC 29925. E-mail: nixna@sjchs.org


J Adv Pract Oncol 2015;6:156–160 | DOI: 10.6004/jadpro.2015.6.2.7 | © 2015 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me